Stereoselective method to quantify bupropion and its three major metabolites, hydroxybupropion, erythro-dihydrobupropion, and threo-dihydrobupropion using HPLC-MS/MS.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

• Publication date

  2016-03-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jchromb.2016.02.018PMID 26946423PMCID PMC4866593
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice

  2014cited by this paper
• Deeper insight into the reducing biotransformation of bupropion in the human liver.

  2014cited by this paper
• Influence of CYP2B6 genetic variants on plasma and urine concentrations of bupropion and metabolites at steady state

  2013influential reference
• Formation of Threohydrobupropion from Bupropion Is Dependent on 11β-Hydroxysteroid Dehydrogenase 1

  2013influential reference
• Bupropion

  2012cited by this paper
• CYP2B6 and Bupropion's Smoking‐Cessation Pharmacology: The Role of Hydroxybupropion

  2012cited by this paper
• A major metabolite of bupropion reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets

  2011cited by this paper
• PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel

  2010cited by this paper
• Convulsive liability of bupropion hydrochloride metabolites in Swiss albino mice

  2008cited by this paper
• Stereoselective Bupropion Hydroxylation as an In Vivo Phenotypic Probe for Cytochrome P4502B6 (CYP2B6) Activity

  2008influential reference
• Bupropion: a review of its use in the management of major depressive disorder.

  2008cited by this paper
• Stereoselective analysis of hydroxybupropion and application to drug interaction studies.

  2007cited by this paper
• Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro.

  2007cited by this paper
• Stereoselective analysis of bupropion and hydroxybupropion in human plasma and urine by LC/MS/MS.

  2007cited by this paper
• Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

  2006cited by this paper
• The functional role of CYP2B6 in human drug metabolism: substrates and inhibitors in vitro, in vivo and in silico.

  2006cited by this paper
• Effect of Clopidogrel and Ticlopidine on Cytochrome P450 2B6 Activity as Measured by Bupropion Hydroxylation

  2005cited by this paper
• The disposition of bupropion and its metabolites in healthy male volunteers after single and multiple doses

  2004cited by this paper
• A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor.

  2004cited by this paper
• Pharmacokinetics of bupropion, a novel antidepressant agent, following oral administration to healthy subjects

  2004cited by this paper
• Enantioselective Effects of Hydroxy Metabolites of Bupropion on Behavior and on Function of Monoamine Transporters and Nicotinic Receptors

  2004cited by this paper
• Behavioral and biochemical investigations of bupropion metabolites.

  2003cited by this paper
• Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity.

  2000influential reference
• CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.

  2000influential reference
• Enantiomeric determination of the phenylmorpholinol metabolite of bupropion in human plasma using coupled achiral-chiral liquid chromatography.

  1997cited by this paper
• Bupropion: a review of its mechanism of antidepressant activity.

  1995cited by this paper
• Antidepressant profile of bupropion and three metabolites in mice.

  1990cited by this paper
• Bupropion in depression. II. The role of metabolites in clinical outcome.

  1988cited by this paper
• Effect of plasma from patients containing bupropion and its metabolites on the uptake of norepinephrine.

  1986cited by this paper
• Pharmacokinetics of bupropion and its major basic metabolites in normal subjects after a single dose

  1985cited by this paper
• Metabolism and kinetics of bupropion.

  1983cited by this paper
• Clinical pharmacokinetics of bupropion: a review.

  1983cited by this paper

• Precision medication based on the evaluation of drug metabolizing enzyme and transporter functions

  2025cites this paper
• The strong clinical interaction between bupropion and CYP2D6 is primarily mediated through bupropion metabolites and their stereoisomers: A paradigm for evaluating metabolites in drug-drug interaction risk.

  2025cites this paper
• Determination of bupropion by off-line coupling Fe3O4@CuO&GO nanocomposite and ion mobility spectrometry with application to biological samples

  2023cites this paper
• Characterization of the Stereoselective Disposition of Bupropion and Its Metabolites in Rat Plasma and Brain

  2023cites this paper
• Enantiomeric separation of bupropion by liquid chromatography on derivatized cyclofructan chiral stationary phase.

  2022cites this paper
• Influence of CYP2B6 Pharmacogenetics on Stereoselective Inhibition and Induction of Bupropion Metabolism by Efavirenz in Healthy Volunteers

  2022cites this paper
• Stereoselective Metabolism of Bupropion to Active Metabolites in Cellular Fractions of Human Liver and Intestine

  2022cites this paper
• Quality Evaluation of Taxilli Herba from Different Hosts Based on Simultaneous Determination of Multiple Bioactive Constituents Combined with Multivariate Statistical Analysis

  2021influential citation
• New-generation, non-SSRI antidepressants: Drug-drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others.

  2020cites this paper
• Population model analysis of chiral inversion and degradation of bupropion enantiomers, and application to enantiomer specific fraction unbound determination in rat plasma and brain.

  2020cites this paper
• Review on analytical methods for quantification of ADHD drugs in human biological samples

  2020cites this paper
• A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: Study design and procedures.

  2020cites this paper
• Enantioselective separation of bupropion and its major metabolite hydroxybupropion: An experimental and theoretical study

  2019cites this paper
• Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects

  2019cites this paper
• Determination of hydroxybupropion in human serum for routine therapeutic drug monitoring in psychiatry: A tool for dose-individualization in treatment with bupropion.

  2019cites this paper
• Simultaneous Quantitative Determination of Bupropion and its Metabolites by High Performance Liquid Chromatography Tandem Mass Spectrometry Detection: Application to Bioequivalence Study

  2018cites this paper
• Comparison of Multiple Bioactive Constituents in Different Parts of Eucommia ulmoides Based on UFLC-QTRAP-MS/MS Combined with PCA

  2018cites this paper
• Quality evaluation of Eucommiae Cortex processed by different methods and "sweating" conditions based on simultaneous determination of multiple bioactive constituents combined with gray relational analysis.

  2018cites this paper
• Comparison of In Vitro Stereoselective Metabolism of Bupropion in Human, Monkey, Rat, and Mouse Liver Microsomes

  2018cites this paper
• Chirality and neuropsychiatric drugs: an update on stereoselective disposition and clinical pharmacokinetics of bupropion

  2018influential citation
• Design of experiment assisted concurrent enantioseparation of bupropion and hydroxybupropion by high-performance thin-layer chromatography.

  2017cites this paper
• Assessment of critical extraction and chromatographic parameters for the determination of bupropion and its three primary metabolites in human plasma by LC-MS/MS

  2017cites this paper
• Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers

  2016cites this paper
• One-step lipase-catalysed preparation of eslicarbazepine

  2016cites this paper
• Stereoselective disposition of bupropion and its three major metabolites : 4-hydroxybupropion, erythro-dihydrobupropion, and threo-dihydrobupropion

  2016cites this paper
• Quality Evaluation of Scrophulariae Radix Processed by Different ‘Sweating’ Methods Based on Simultaneous Determination of Multiple Bioactive Constituents Combined with Grey Relational Analysis

  2016cites this paper